Dr. Samuel Edward Horr, MD

Dr. Horr practices at TriStar Centennial Medical Center in Nashville, Tennessee, part of HCA Healthcare.

Dr. Horr's NPI, 1417273061, was assigned on April 7, 2010. Dr. Horr holds Tennessee license 57222.

Dr. Horr's primary practice is TriStar Centennial Medical Center, at 2300 Patterson Street, Nashville, TN 37203 in Davidson County. The practice phone is (615) 342-1000.

Dr. Horr's primary practice is TriStar Centennial Medical Center in Nashville, Tennessee, part of HCA Healthcare. Dr. Horr is also affiliated with Williamson Medical Center. The medical group on file is Centennial Heart Cardiovascular Consultants. Dmand AI also links Dr. Horr to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Horr practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Horr's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Horr's licenses on file in 2 states: Tennessee and Ohio.

CMS data shows 1,473 Medicare services from Dr. Horr across 25 procedure codes in 2024, for 495 Medicare patients. Medicare paid $150,810 for them.

CMS counts 495 Medicare patients who saw Dr. Horr in 2024. The largest group is 75 to 84, with 205 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Horr's median patient age at 75, with 42% women.

In 2024, Dr. Horr wrote 802 Medicare Part D claims for 228 patients. 83% of them were for generic drugs. CMS names the drug for 639 of them, across 18 drugs with 11 or more claims each, at $96,407 in total drug cost. In 2023, CMS named 933 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Horr for performance year 2024, reported as part of a group. Dr. Horr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Horr as offering telehealth. CMS counts 29 procedures of coronary angioplasty and stenting by Dr. Horr, more than 64% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Horr, published from 2012 to 2024. 2017 was the busiest year, with 2. The most frequent topics are Myocardial Infarction. Dr. Horr's most frequent co-authors are Khawaja A. Ammar, MD, Ezana M. Azene, MD, PhD and Brian Allan Bergmark, MD.

Dmand AI links Dr. Horr to 4 clinical trials. 3 are still active or recruiting. Conditions studied include Heart Valve Diseases, Atrial Fibrillation and Mitral Valve Insufficiency. Boston Scientific Corporation sponsors the most, 2.

CMS Open Payments shows 703 general payments to Dr. Horr from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Edwards Lifesciences Corporation paid the most, $62,785.